Gonano, Christopher <br/><br/>
Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis.  [electronic resource] 

 -  Critical care (London, England)  2006 
 - R160 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1466-609X 
<br/><br/><label>Standard No.: </label>10.1186/cc5098  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antithrombins--pharmacology<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Fibrinogen--analysis<br/>Humans<br/>Male<br/>Middle Aged<br/>Platelet Count<br/>Sepsis--complications<br/>Thrombophilia--drug therapy